Shu-jun Yang

Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A multicenter randomized, controlled clinical trial of adjuvant sintilimab for esophageal squamous cell carcinoma.

A multicenter randomized, controlled clinical trial of adjuvant sintilimab for esophageal squamous cell carcinoma.

Journal: Future oncology (London, England)

Published: September 22, 2023

A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).

A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).

Journal: Journal of cancer research and clinical oncology

Published: February 05, 2021

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 25, 2021

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903).

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903).

Journal: BMC cancer

Published: March 13, 2020

L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma.

L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 06, 2018

Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis.

Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis.

Journal: Gynecologic oncology

Published: May 03, 2018

Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma.

Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma.

Journal: OncoTargets and therapy

Published: October 08, 2016

A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma.

A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma.

Journal: Oncotarget

Published: July 18, 2016

Expression of activating transcription factor 7 is correlated with prognosis of colorectal cancer.

Expression of activating transcription factor 7 is correlated with prognosis of colorectal cancer.

Journal: Journal of cancer research and therapeutics

Published: July 08, 2015

Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK/T-cell lymphoma.

Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK/T-cell lymphoma.

Journal: Molecular and clinical oncology

Published: May 23, 2014

p63 Expression is a prognostic factor in colorectal cancer.

p63 Expression is a prognostic factor in colorectal cancer.

Journal: The International journal of biological markers

Published: August 01, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026